Impact of Personality on Adherence to Tyrosine Kinase Inhibitor Therapy in Pts w/Chronic Myeloid Leukemia

Part of paid clinical trials in Orange, California.

Sponsor
University of California, Irvine
Study ID
NCT06229860
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Interview — OTHER
    In-person interview with the study coordinator to complete study questionnaire.

Study Details

This is an observational pilot study to examine the association between a patient's personality and adherence to tyrosine kinase inhibitor therapy in patients with chronic myeloid leukemia.

Key Dates

Start date
Jan 25, 2024
Status verified
Mar 2026
Primary completion
Mar 19, 2025
Completion
Dec 31, 2026

Study Design

Enrollment
75 participants (estimated)

Arms

  • Arm: Adult patients with CML in chronic phase (CML-CP)

Primary Outcome Measure

Assessment of adherence to TKI medication [ Time Frame: Up to 1 year ]

Central Contacts

  • Chao Family Comprehensive Cancer Center University of California, Irvine
    1-877-827-8839
    [email protected]
  • University of California Irvine Medical

Locations (1)

FacilityCityStateZIPSite coordinators
Chao Family Comprehensive Cancer Center University of California, IrvineOrangeCalifornia92868
Mahtab Jafari, Pharm.D
[email protected]
877-827-8839

Find similar trials in Orange, CA

By condition
Leukemia (other)
By specialty
OncologyBlood cancer
By research site
Chao Family Comprehensive Cancer Center University of California, Irvine· Orange, CA

Related Studies